REGENCELL BIOSCIENCE HLDGS L's ticker is and the CUSIP is G7487R100. A total of 6 filers reported holding REGENCELL BIOSCIENCE HLDGS L in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,190 | +23700.0% | 85 | -57.5% | 0.00% | – |
| Q1 2023 | $5 | -100.0% | 200 | -46.2% | 0.00% | – |
| Q3 2022 | $12,000 | -40.0% | 372 | -35.6% | 0.00% | – |
| Q2 2022 | $20,000 | +100.0% | 578 | +33.8% | 0.00% | – |
| Q1 2022 | $10,000 | -86.5% | 432 | -86.8% | 0.00% | -100.0% |
| Q3 2021 | $74,000 | – | 3,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 85 | $1,190 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 326 | $4,564 | 0.00% |
| BlackRock Inc. | 238 | $3,332 | 0.00% |
| Qube Research & Technologies Ltd | 13 | $185 | 0.00% |